Table 1.

ID	GA	Clinic Visit	Phallic Stretched Length**	Phallic Midshaft Diameter**	Hypospadias Degree	Gonadal Location	Testosterone*** (ng/dL)	DHT*** (pg/mL)	LH*** (IU/L)	FSH*** (IU/L)	Clinical AR Sequencing	Non-GU Abnormalities
1*	39.1	Both	2.1	0.9	Penoscrotal	Scrotal	195	193	4.34	NR	Y, no diagnosis	None
2*	40.9	Both	2	1	Perineal	Scrotal	177	301	8.93	7.97	N	None
3	40.0	Urology	NR	NR	No hypospadias	Scrotal	NR	NR	NR	NR	N	Tethered cord, anteriorly placed anus, renal abnormalities
4	33.0	Both	2.5	1.1	Penoscrotal	Scrotal	132	462	3	3.34	N	Intrauterine growth restriction
5	41.0	Both	3.2	1.1	Perineal	Inguinal	NR	NR	NR	NR	N	None
6	34.7	Both	NR	NR	Scrotal	Scrotal	207	71	NR	NR	Y, no diagnosis	None
7	37.0	Both	NR	NR	Scrotal	Scrotal	NR	NR	NR	NR	N	Global developmental delay
8	35.3	Urology	NR	NR	Penoscrotal	Scrotal	NR	NR	NR	NR	N	None
9	39.1	Urology	NR	NR	Glanular	Scrotal	NR	NR	NR	NR	N	Ventricular Septal Defect
10	39.0	Both	2	1.1	Perineal	Scrotal	85.9	29	5.23	4.62	N	None

GA, Gestational age in weeks

NR, not reported

Clinic visit: Endocrinology, Urology or both (at any point in the EMR)

Testosterone: ng/dL * 0.03467 = nmol/L

Dihydrotestosterone: pg/mL * 0.003443 = nmol/L

^*Subjects found to have NR5A1 presumed pathogenic variants

^**In cm, initial measurement reported between birth and 3 months of age)

^***Baseline measurement between 2 weeks and 3 months